# Novel MRI ANd Biomarkers in GOlimumab-treated Patients With Axial Spondyloarthritis

> **NCT02011386** · — · COMPLETED · sponsor: **Professor Mikkel Østergaard** · enrollment: 53 (actual)

## Conditions studied

- Axial Spondyloarthritis

## Interventions

- **DRUG:** Treatment

## Key facts

- **NCT ID:** NCT02011386
- **Lead sponsor:** Professor Mikkel Østergaard
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2017-02-14
- **Final completion:** 2017-02-14
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2020-08-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02011386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02011386, "Novel MRI ANd Biomarkers in GOlimumab-treated Patients With Axial Spondyloarthritis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02011386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*